Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: A randomized sham-controlled study

Circulation

Volumn 122, Issue 16, 2010, Pages 1612-1620

  Braith, Randy W ^a,b   Conti, C Richard ^b   Nichols, Wilmer W ^b   Choi, Calvin Y ^b   Khuddus, Matheen A ^b   Beck, Darren T ^a   Casey, Darren P ^c  

^a 229 A Richards Building   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

angina; endothelin; inflammation; nitric oxide; vasodilation

Indexed keywords

6 KETO PROSTAGLANDIN F1 ALPHA; 8 ISOPROSTANE; C REACTIVE PROTEIN; ENDOTHELIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE; PROSTAGLANDIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; 6 OXOPROSTAGLANDIN F1 ALPHA; CYTOKINE; NITRIC OXIDE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; COUNTERPULSATION; ECHOGRAPHY; ENHANCED EXTERNAL COUNTERPULSATION; FEMALE; FEMORAL ARTERY; HEART HEMODYNAMICS; HUMAN; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SHEAR STRESS; STABLE ANGINA PECTORIS; AGED; ANGINA PECTORIS; BLOOD; BLOOD FLOW; BLOOD PRESSURE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXERCISE TOLERANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

6-KETOPROSTAGLANDIN F1 ALPHA; AGED; ANGINA PECTORIS; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHRONIC DISEASE; COUNTERPULSATION; CYTOKINES; ENDOTHELIN-1; EXERCISE TOLERANCE; FEMORAL ARTERY; HUMANS; MIDDLE AGED; NITRIC OXIDE; OXYGEN CONSUMPTION; REGIONAL BLOOD FLOW; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 78049519341     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.923482     Document Type: Article

References (39)

1. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto RW. The Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833-1840.
2. Lawson WE, Hui JC, Zheng ZS, Burgen L, Jiang L, Lillis O, Oster Z, Soroff H, Cohn P. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology. 1996;87:271-275.
3. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93-99.
4. Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, Inubushi M, Tadamura E, Fujita M, Sasayama S. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina: evaluation by (13) N-ammonia positron emission tomography. Eur Heart J. 2001;22:1451-1458.
5. Stys TP, Lawson WE, Hui JC, Fleishman B, Manzo K, Strobeck JE, Tartaglia J, Ramasamy S, Suwita R, Zheng ZS, Liang H, Werner D. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822-824.
6. Michaels AD, Raisinghani A, Soran O, de Lame PA, Lemaire ML, Kligfield P, Watson DD, Conti CR, Beller G. The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study. Am Heart J. 2005;150:1066-1073.
7. Bonetti PO, Holmes DR Jr, Lerman A, Barsness GW. Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? J Am Coll Cardiol. 2003;41:1918-1925.
8. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B-74B.
9. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract. 2009;6:16-26.
10. Pannala AS, Mani AR, Spencer JP, Skinner V, Bruckdorfer KR, Moore KP, Rice-Evans CA. The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic Biol Med. 2003;34:576-584.
11. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
12. Pyke KE, Dwyer EM, Tschakovsky ME. Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. J Appl Physiol. 2004;97:499-508.
13. Shechter M, Matetzky S, Feinberg MS, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol. 2003;42:2090-2095.
14. Akhtar M, Wu GF, Du ZM, Zheng ZS, Michaels AD. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol. 2006;98:28-30.
15. Tanzilli G, Barilla F, Pannitteri G, Greco C, Comito C, Schiariti M, Papalia U, Mangieri E. Exercise training counteracts the abnormal release of plasma endothelin-1 in normal subjects at risk for hypertension. Ital Heart J. 2003;4:107-112.
16. Maeda S, Miyauchi T, Iemitsu M, Sugawara J, Nagata Y, Goto K. Resistance exercise training reduces plasma endothelin-1 concentration in healthy young humans. J Cardiovasc Pharmacol. 2004;44(suppl 1):S443-S446.
17. Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, Du Z, Jin Y, Xiong Y, He J, Fang D, Wang K, Lawson WE, Hui JC, Zheng Z, Wu G. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007;116:526-534.
18. Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr. 2005;117:816-820.
19. Richter B, Niessner A, Penka M, Grdic M, Steiner S, Strasser B, Ziegler S, Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, Huber K. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost. 2005;94:1306-1311.
20. Sydow K, Munzel T. ADMA and oxidative stress. Atherosclerosis. 2003;4:41-51.
21. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007;49:2379-2393.
22. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation. 2002;106:1237-1242.
23. Nichols WW, Estrada JC, Braith RW, Owens K, Conti CR. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol. 2006;48:1208-1214.
24. Pagonas N, Utz W, Schulz-Menger J, Busjahn A, Monti J, Thierfelder L, Dietz R, Klauss V, Gross M, Buschmann IR, Buschmann EE. Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements: design of the Arteriogenesis Network Trial 2. Int J Cardiol. 2009 Jun. 16 [Epub ahead of print].
25. Buschmann EE, Utz W, Pagonas N, Schulz-Menger J, Busjahn A, Monti J, Maerz W, le Noble F, Thierfelder L, Dietz R, Klauss V, Gross M, Buschmann IR. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art. Net.-2 Trial). Eur J Clin Invest. 2009;39:866-875.
26. Ozawa ET, Bottom KE, Xiao X, Kamm RD. Numerical simulation of enhanced external counterpulsation. Ann Biomed Eng. 2001;29:284-297.
27. Green D. Exercise training as vascular medicine: direct impacts on the vasculature in humans. Exercise Sport Sci Rev. 2009;37:196-202.
28. Balady GJ, Chaitman B, Driscoll D, Foster C, Froelicher E, Gordon N, Pate R, Rippe J, Bazzarre T. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation. 1998;97:2283-2293.
29. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999;100:793-798.
30. Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L, Brunsvig A, Muller F, Forfang K, Froland SS, Gullestad L. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol. 2001;37:485-491.
31. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem. 2008;41:126-133.
32. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336-1342.
33. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
34. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149-2153.
35. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med. 2006;259:351-363.
36. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis. 2006;184:425-430.
37. Holmes DR Jr. Treatment options for angina pectoris and the future role of enhanced external counterpulsation. Clin Cardiol. 2002;25:II22-I125.
38. Nichols WW, ed. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles. 5th ed. London, UK: Edward Arnold; 2005.
39. Hashemi M, Hoseinbalam M, Khazaei M. Long-term effect of enhanced external counterpulsation on endothelial function in the patients with intractable angina. Heart Lung Circ. 2008;17:383-387.